Navarro, RP, Flood, J. et. al. Contemporary management strategies for fibromyalgia. Am J Manag Care. 2009;15(7) suppl S197-S218.
Flood J: Tumor Necrosis Factor (TNF) Inhibitors: A review of structure, function, and mechanism of action. ManagedCare.2008;17(suppl4):2-4. Also in Biotechnology Healthcare. 2008;5 (suppl 3):2-4.
Flood J. Tumor Necrosis Factor Inhibitors: A review of dosing patterns and related economic considerations.ManagedCare.2008;17(11):1-5. Also in Biotechnology Healthcare. 2008;5(suppl 4):1-5.
Flood J. Tumor Necrosis Factor Inhibitors in the Treatment of Chronic Inflammatory Diseases: A review of immunogenicity and potential implications. Managed Care. 2009:18 (suppl 3):1-5. Also in BiotechnologyHealthcare.2009:6(suppl2):1-5. Also in Pharmacy & Therapeutics. 2009:33(suppl 2):1-5
Flood, J: Rheumatology Consult, a regular column in the newsletter of the Fibromyalgia Alliance of America, 1990-96.
Flood, J: Effectiveness and safety of oxaprosin versus aspirin for rheumatoid arthritis. J Musculoskel Med 1993: 10 (3, suppl): S38-S44.
Ryan, KP, Flood, J, et al: Cerebrospinal fluid CEA. A sensitive assay in the clinical management and early diagnosis of central nervous system metastases in patients with advanced breast cancer. Plenary session presented at the American College of Physicians Regional Meeting, San Antonio, Texas, 1983. Goldman Award for Associate's Paper.
Ryan, KP, Flood, J: Can intracranial metastases be followed and reliably predicted by cerebrospinal fluid and tumor-associated antigens in patients with breast carcinoma and non-Hodgkins lymphoma? American College of Physicians Regional Meeting, Sacramento, California, 1982. Second place, Associate's Award.